Results 241 to 250 of about 332,122 (357)

Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. [PDF]

Indian J Crit Care Med
Karim HMR, Khandelwal A, Atlapure B, Aspari A.   +3 more
europepmc   +1 more source

Effects of volatile anesthetics on endothelium- dependent rhythmic oscillations in contractile response to norepinephrine and acetylcholine-induced relaxant response.

, 1993
Takashi Akata, Kenji Kodama, Shosuke Takahashi   +2 more
openalex   +1 more source

Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters [PDF]

, 2004
Lankupalle D. Jayanthi, Devadoss J. Samuvel, Sammanda Ramamoorthy   +2 more
openalex   +1 more source

Norepinephrine Controls Astroglial Responsiveness to Local Circuit Activity

Neuron, 2014
Martin Paukert, A. Agarwal, J. Cha, V. Doze, Jin U. Kang, D. Bergles   +5 more
semanticscholar   +1 more source

Factors Associated With Non‐Vasomotor Menopause Symptoms Experienced by 7285 Women: A UK‐Wide National Survey

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To investigate the factors associated with non‐vasomotor menopause symptoms among women in the UK, focusing on the perceived importance of specific symptoms and their association with demographic and treatment‐related factors. Design A cross‐sectional online survey.
Rhianna Davies, Ashwin Goyal, Zachary Nash, Sarah Hillman, Melanie Davies, Nick Panay, Jane Daniels, Tim Hillard, Bonnie Grant, Paula Briggs, Lynne Robinson, Haitham Hamoda, Channa N. Jayasena   +12 more
wiley   +1 more source

Glucose may be biotransformed and then react with alcohol, fats, endocannabinoids, or various amino acids to form dopamine or norepinephrine <i>in vivo</i>. [PDF]

Front Pharmacol
Fitzgerald PJ.
europepmc   +1 more source

Contribution of mitochondrial Ca2+ to norepinephrine release evoked by ouabain and monensin

, 1986
Takeshi Katsuragi, Koji Miyamoto, Lulu Kuratomi, Tatsuo Furukawa   +3 more
openalex   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Epinephrine vs Norepinephrine as the Initial Vasoactive Agent in Pediatric Septic Shock: A Feasibility Randomized Controlled Trial for Recruitment Rates and Protocol Adherence, the Epinephrine vs Norepinephrine in Pediatric Septic Shock (EPINESS) Trial. [PDF]

Indian J Crit Care Med
Nataraj R, Dalal P, Vijayaraghavan BK, Venkatachalam P, Kumar V, Chidambaram L, Schlapbach LJ, Kissoon N, Ranjit S.   +8 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source